Causes and consequences of methamphetamine and MDMA toxicity

Maria S. Quinton, Bryan Yamamoto

Research output: Contribution to journalReview article

145 Citations (Scopus)

Abstract

Methamphetamine (METH) and its derivative 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) are 2 substituted amphetamines with very high abuse liability in the United States. These amphetamine-like stimulants have been associated with loss of multiple markers for dopaminergic and serotonergic terminals in the brain. Among other causes, oxidative stress, excitotoxicity and mitochondrial dysfunction appear to play a major role in the neurotoxicity produced by the substituted amphetamines. The present review will focus on these events and how they interact and converge to produce the monoaminergic depletions that are typically observed after METH or MDMA administration. In addition, more recently identified consequences of METH or MDMA-induced oxidative stress, excitotoxicity, and mitochondrial dysfunction are described in relation to the classical markers of METH-induced damage to dopamine terminals.

Original languageEnglish (US)
Article number38
JournalAAPS Journal
Volume8
Issue number2
DOIs
StatePublished - May 12 2006
Externally publishedYes

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Methamphetamine
Amphetamines
Oxidative Stress
Amphetamine
Dopamine
Brain

Keywords

  • Blood-brain barrier
  • Excitotoxicity
  • Glutamate
  • Mitochondrial dysfunction
  • Oxidative stress
  • Substituted amphetamines

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Causes and consequences of methamphetamine and MDMA toxicity. / Quinton, Maria S.; Yamamoto, Bryan.

In: AAPS Journal, Vol. 8, No. 2, 38, 12.05.2006.

Research output: Contribution to journalReview article

@article{ea0d8ae2462842f9b9739df8c399c6df,
title = "Causes and consequences of methamphetamine and MDMA toxicity",
abstract = "Methamphetamine (METH) and its derivative 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) are 2 substituted amphetamines with very high abuse liability in the United States. These amphetamine-like stimulants have been associated with loss of multiple markers for dopaminergic and serotonergic terminals in the brain. Among other causes, oxidative stress, excitotoxicity and mitochondrial dysfunction appear to play a major role in the neurotoxicity produced by the substituted amphetamines. The present review will focus on these events and how they interact and converge to produce the monoaminergic depletions that are typically observed after METH or MDMA administration. In addition, more recently identified consequences of METH or MDMA-induced oxidative stress, excitotoxicity, and mitochondrial dysfunction are described in relation to the classical markers of METH-induced damage to dopamine terminals.",
keywords = "Blood-brain barrier, Excitotoxicity, Glutamate, Mitochondrial dysfunction, Oxidative stress, Substituted amphetamines",
author = "Quinton, {Maria S.} and Bryan Yamamoto",
year = "2006",
month = "5",
day = "12",
doi = "10.1208/aapsj080238",
language = "English (US)",
volume = "8",
journal = "AAPS Journal",
issn = "1550-7416",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Causes and consequences of methamphetamine and MDMA toxicity

AU - Quinton, Maria S.

AU - Yamamoto, Bryan

PY - 2006/5/12

Y1 - 2006/5/12

N2 - Methamphetamine (METH) and its derivative 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) are 2 substituted amphetamines with very high abuse liability in the United States. These amphetamine-like stimulants have been associated with loss of multiple markers for dopaminergic and serotonergic terminals in the brain. Among other causes, oxidative stress, excitotoxicity and mitochondrial dysfunction appear to play a major role in the neurotoxicity produced by the substituted amphetamines. The present review will focus on these events and how they interact and converge to produce the monoaminergic depletions that are typically observed after METH or MDMA administration. In addition, more recently identified consequences of METH or MDMA-induced oxidative stress, excitotoxicity, and mitochondrial dysfunction are described in relation to the classical markers of METH-induced damage to dopamine terminals.

AB - Methamphetamine (METH) and its derivative 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) are 2 substituted amphetamines with very high abuse liability in the United States. These amphetamine-like stimulants have been associated with loss of multiple markers for dopaminergic and serotonergic terminals in the brain. Among other causes, oxidative stress, excitotoxicity and mitochondrial dysfunction appear to play a major role in the neurotoxicity produced by the substituted amphetamines. The present review will focus on these events and how they interact and converge to produce the monoaminergic depletions that are typically observed after METH or MDMA administration. In addition, more recently identified consequences of METH or MDMA-induced oxidative stress, excitotoxicity, and mitochondrial dysfunction are described in relation to the classical markers of METH-induced damage to dopamine terminals.

KW - Blood-brain barrier

KW - Excitotoxicity

KW - Glutamate

KW - Mitochondrial dysfunction

KW - Oxidative stress

KW - Substituted amphetamines

UR - http://www.scopus.com/inward/record.url?scp=33646920890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646920890&partnerID=8YFLogxK

U2 - 10.1208/aapsj080238

DO - 10.1208/aapsj080238

M3 - Review article

C2 - 16796384

AN - SCOPUS:33646920890

VL - 8

JO - AAPS Journal

JF - AAPS Journal

SN - 1550-7416

IS - 2

M1 - 38

ER -